Exagen Inc (XGN) Stock Up 30.39%: Latest Performance Analysis

A share price of Exagen Inc [XGN] is currently trading at $3.99, up 30.39%. An important factor to consider is whether the stock is rising or falling in short-term value. The XGN shares have gain 25.87% over the last week, with a monthly amount drifted -33.50%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Exagen Inc [NASDAQ: XGN] stock has seen the most recent analyst activity on August 05, 2022, when KeyBanc Capital Markets downgraded its rating to a Sector Weight. On April 15, 2021, Canaccord Genuity initiated with a Buy rating and assigned a price target of $25 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and suggested a price target of $32 on November 10, 2020. BTIG Research initiated its recommendation with a Buy and recommended $18 as its price target on October 08, 2020. In a note dated October 14, 2019, William Blair initiated an Outperform rating.

Exagen Inc experienced fluctuations in its stock price throughout the past year between $1.30 and $6.22. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Exagen Inc [NASDAQ: XGN] shares were valued at $3.99 at the most recent close of the market. An investor can expect a potential return of 25.31% based on the average XGN price forecast.

Analyzing the XGN fundamentals

Trailing Twelve Months sales for Exagen Inc [NASDAQ:XGN] were 55.75M which represents -6.78% decline. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -0.3%, and Net Profit Margin reading is -0.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.93 and Total Capital is -0.44. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.81.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.32 points at the first support level, and at 2.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.37, and for the 2nd resistance point, it is at 4.76.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Exagen Inc [NASDAQ:XGN] is 4.05. On the other hand, the Quick Ratio is 3.72, and the Cash Ratio is 2.51. Considering the valuation of this stock, the price to sales ratio is 1.26, the price to book ratio is 5.43.

Transactions by insiders

Recent insider trading involved NMSIC Co-Investment Fund, L.P., 10% Owner, that happened on Nov 20 ’24 when 0.2 million shares were sold. Chief Financial Officer, Black Jeffrey G. completed a deal on Nov 15 ’24 to buy 22298.0 shares. Meanwhile, President and CEO ABALLI JOHN bought 24305.0 shares on Nov 14 ’24.

Related Posts